These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37566732)

  • 21. Vitiligo and quality of life: the dark face of whiteness.
    Ezzedine K; Eleftheriadou V
    Br J Dermatol; 2018 Jan; 178(1):28-29. PubMed ID: 29357599
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser.
    Murakami K; Saito Y; Takeuchi S; Sujino K; Tanikawa A; Tanese K; Fukuda K
    Eur J Dermatol; 2023 Aug; 33(4):428-430. PubMed ID: 37823495
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitiligo.
    Okoro U; Usatine RP; Heath CR
    Cutis; 2023 Feb; 111(2):106-107. PubMed ID: 37075191
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitiligo.
    LeWitt TM; Kundu RV
    JAMA Dermatol; 2021 Sep; 157(9):1136. PubMed ID: 34287629
    [No Abstract]   [Full Text] [Related]  

  • 25. Global recommendations for vitiligo management.
    Ring J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2157-2158. PubMed ID: 37877761
    [No Abstract]   [Full Text] [Related]  

  • 26. Eight-year sustained efficacy and safety of fractional CO
    Helou J; Soutou B
    J Cosmet Dermatol; 2022 Nov; 21(11):6518-6520. PubMed ID: 35980675
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Cosmetic Camouflage in Adults With Vitiligo.
    Morales-Sánchez MA; Laguna-Meraz JP; Peralta-Pedrero ML; Jurado-Santa Cruz F
    Actas Dermosifiliogr; 2022 Mar; 113(3):316-318. PubMed ID: 35526927
    [No Abstract]   [Full Text] [Related]  

  • 28. Using methotrexate in the treatment of advanced vitiligo.
    Tavitova A; Valle Y; Lomonosov K
    J Cosmet Dermatol; 2023 Mar; 22(3):1136-1138. PubMed ID: 36409563
    [No Abstract]   [Full Text] [Related]  

  • 29. Axillary incubator for cell-based therapies in vitiligo.
    Bhatia S; Rajput L; Gupta S
    J Am Acad Dermatol; 2021 Nov; 85(5):e279-e280. PubMed ID: 32222452
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
    Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2022; 88(5):691-695. PubMed ID: 35962518
    [No Abstract]   [Full Text] [Related]  

  • 31. Vitiligo effectively treated with electrocautery needling technique.
    Yang L; Wong PM; Yang L; Katayama I; Wu H; Zhang H
    Dermatol Ther; 2020 Nov; 33(6):e14154. PubMed ID: 32767488
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of noncultured melanocyte-keratinocyte cell suspension vs hair follicular cell suspension transfer in stable vitiligo: A randomized controlled trial.
    Moosavi Z; Miramin Mohammadi A; Tavakkoli K; Daniel VT; Variji Z; Javadi A; Feizi Konjini L; Firooz A
    Dermatol Ther; 2020 May; 33(3):e13309. PubMed ID: 32162392
    [No Abstract]   [Full Text] [Related]  

  • 33. British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
    Eleftheriadou V; Atkar R; Batchelor J; McDonald B; Novakovic L; Patel JV; Ravenscroft J; Rush E; Shah D; Shah R; Shaw L; Thompson AR; Hashme M; Exton LS; Mohd Mustapa MF; Manounah L;
    Br J Dermatol; 2022 Jan; 186(1):18-29. PubMed ID: 34160061
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment recommendations for patients with vitiligo during COVID-19.
    Rodrigues M; Pandya AG; Hamzavi I; Ezzedine K; Bekkenk MW; Harris JE
    Australas J Dermatol; 2021 Aug; 62(3):e481-e482. PubMed ID: 34028796
    [No Abstract]   [Full Text] [Related]  

  • 35. Micropigmentation-A revived therapeutic tool for recalcitrant, difficult-to-treat periungual vitiligo.
    Sharma A; Agrawal S; Dhurat R; Mhatre M; Surve R; Kerure A
    Dermatol Ther; 2020 Jul; 33(4):e13568. PubMed ID: 32401406
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of diversity in vitiligo clinical trials: a cross-sectional analysis.
    Hernandez LE; Verling S; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2735-2736. PubMed ID: 37486414
    [No Abstract]   [Full Text] [Related]  

  • 37. Vitiligo: 30 years to put together the puzzle pieces and to give rise to a new era of therapeutic options.
    Passeron T
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2305-2307. PubMed ID: 34647661
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitiligo treatment with coloured illustration by Turkish physician Şerefeddin Sabuncuoğlu, in the 15th century.
    Serarslan G
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):472-473. PubMed ID: 36462153
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of 308-nm excimer laser treatment for refractory vitiligo: a case series of treatment based on the minimal blistering dose.
    Noborio R; Nomura Y; Nakamura M; Nishida E; Kiyohara T; Tanizaki H; Morita A
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e287-e289. PubMed ID: 33232541
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic options and hot topics in vitiligo with special focus on pediatrics' vitiligo: A comprehensive review study.
    Roohaninasab M; Mansouri P; Seirafianpour F; Naeini AJ; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14550. PubMed ID: 33200859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.